Catalog No.:AA003GYX

4857-06-1 | 2-Chlorobenzimidazole

Name: Name:2-Chlorobenzimidazole
Brand: AABLOCKS
SKU: AA003GYX
Availability: InStock
Rating: 90 (10 reviews)

Pack Size

Purity

Availability

Price(USD)

Quantity

97%

in stock

$6.00 $4.00

- +

97%

in stock

$8.00 $6.00

- +

10g

97%

in stock

$13.00 $9.00

- +

25g

97%

in stock

$24.00 $17.00

- +

100g

97%

in stock

$73.00 $51.00

- +

Technical Information
Properties
Upstream Synthesis Route
Downstream Synthesis Route
Literature
Request for Quotation
Download SDS

Technical Information
Properties
Upstream Synthesis Route
Downstream Synthesis Route
Literature

Technical Information

Catalog Number:

AA003GYX

Chemical Name:

2-Chlorobenzimidazole

CAS Number:

4857-06-1

Molecular Formula:

C7H5ClN2

Molecular Weight:

152.5810

MDL Number:

MFCD00051944

SMILES:

Clc1nc2c([nH]1)cccc2

NSC Number:

111358

Properties

BP:

328.5°C at 760 mmHg

Form:

Solid

MP:

207-211 °C(lit.)

Refractive Index:

1.5500 (estimate)

Stability:

Moisture Sensitive

Storage:

Room Temperature;Light sensitive;Keep in dry area;

Computed Properties

Complexity:

129

Covalently-Bonded Unit Count:

Heavy Atom Count:

Hydrogen Bond Acceptor Count:

Hydrogen Bond Donor Count:

XLogP3:

2.2

Upstream Synthesis Route

615-16-7

4857-06-1

[1]IndianJournalofChemistry-SectionBOrganicandMedicinalChemistry,2005,vol.44,#6,p.1239-1242

[2]JournalofMedicinalChemistry,2016,vol.59,#15,p.7188-7211

[3]ACSInfectiousDiseases,2017,vol.3,#3,p.225-236

[4]AustralianJournalofChemistry,1982,vol.35,#4,p.775-784

[5]AttidellaAccademiaNazionaledeiLincei,ClassediScienzeFisiche,MatematicheeNaturali,Rendiconti,1900,vol.<5>9II,p.271

[6]ZhurnalObshcheiKhimii,1953,vol.23,p.1691,1694;engl.Ausg.S.1779,1781

[7]Patent:US4314065,1982,A,

[8]Patent:US4096263,1978,A,

[9]BioorganicandMedicinalChemistryLetters,2008,vol.18,#18,p.5010-5014

[10]BioorganicandMedicinalChemistryLetters,2014,vol.24,#4,p.1071-1074

[11]JournalofMedicinalChemistry,2018,vol.61,#19,p.8875-8894

615-16-7

4857-06-1

[1]SyntheticCommunications,1996,vol.26,#17,p.3323-3329

[2]JournalofMedicinalChemistry,1986,vol.29,#6,p.1099-1113

[3]JournalofMedicinalChemistry,2011,vol.54,#13,p.4508-4522

[4]JournalofMedicinalChemistry,2012,vol.55,#14,p.6278-6293

[5]JournalofHeterocyclicChemistry,1995,vol.32,#3,p.707-718

[6]Patent:US5461059,1995,A,

[7]Patent:US5149700,1992,A,

[8]Patent:US6756382,2004,B2,

[9]Patent:US2003/144283,2003,A1,

463-73-0

95-54-5

4857-06-1

[1]JournaloftheKoreanChemicalSociety,2010,vol.54,#5,p.589-593

[2]JournaloftheChileanChemicalSociety,2012,vol.57,#2,p.1122-1125,4

615-16-7

4857-06-1

[1]Patent:US5106857,1992,A,

40828-54-4

4857-06-1

[1]SyntheticCommunications,1998,vol.28,#9,p.1703-1712

Downstream Synthesis Route

4857-06-1

506-59-2

2851-13-0

[1]ZhurnalObshcheiKhimii,1953,vol.23,p.1691,1694;engl.Ausg.S.1779,1781

4318-37-0

4857-06-1

101953-62-2

[1]JournalofMedicinalChemistry,1986,vol.29,p.1178-1183

[2]ChemicalandPharmaceuticalBulletin,1999,vol.47,p.1573-1578

4857-06-1

124-40-3

2851-13-0

[1]Patent:EP2740730,2014,A1.Locationinpatent:Paragraph0320

[2]JournaloftheChemicalSociety.PerkintransactionsII,1985,p.1513-1522

4857-06-1

74-89-5

17228-38-5

[1]AngewandteChemie-InternationalEdition,2012,vol.51,p.10364-10367

[2]TetrahedronLetters,2016,vol.57,p.1035-1039

[3]Patent:US2011/306613,2011,A1.Locationinpatent:Page/Pagecolumn29

[4]JournaloftheChemicalSociety.PerkintransactionsII,1985,p.1513-1522

4857-06-1

107-07-3

40019-65-6

[1]PharmaceuticalChemistryJournal,1988,vol.22,p.146-150 Khimiko-FarmatsevticheskiiZhurnal,1988,vol.22,p.195-199

Literature

Title: Cytotoxic activity, X-ray crystal structures and spectroscopic characterization of cobalt(II), copper(II) and zinc(II) coordination compounds with 2-substituted benzimidazoles.

Journal: Journal of inorganic biochemistry 20090901

Title: Functional group interactions of a 5-HT3R antagonist.

Journal: BMC biochemistry 20020101

Quotation Request

Company Name:

Contact Person:

Email:

Quantity Required:

Country:

Additional Info:

SDS